Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India
It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lobeglitazone
In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults
With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…